[HTML][HTML] The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled …

M Zarrabi, MG Akbari, M Amanat, A Majmaa… - BMC neurology, 2022 - Springer
Introduction The current multi-center, randomized, double-blind study was conducted among
children with cerebral palsy (CP) to assess the safety and efficacy of umbilical cord blood …

[HTML][HTML] The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled …

M Zarrabi, MG Akbari, M Amanat… - BMC …, 2022 - bmcneurol.biomedcentral.com
The current multi-center, randomized, double-blind study was conducted among children
with cerebral palsy (CP) to assess the safety and efficacy of umbilical cord blood …

The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial.

M Zarrabi, MG Akbari, M Amanat, A Majmaa… - BMC …, 2022 - europepmc.org
Methods Males and females aged 4 to 14 years old with spastic CP were included. Eligible
participants were allocated in 4: 1 ratio to be in the experimental or control groups; …

The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial.

M Zarrabi, MG Akbari, M Amanat, A Majmaa… - BMC …, 2022 - go.gale.com
Introduction The current multi-center, randomized, double-blind study was conducted among
children with cerebral palsy (CP) to assess the safety and efficacy of umbilical cord blood …

The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial

M Zarrabi, MG Akbari, M Amanat, A Majmaa… - BMC …, 2022 - pure.johnshopkins.edu
Introduction: The current multi-center, randomized, double-blind study was conducted
among children with cerebral palsy (CP) to assess the safety and efficacy of umbilical cord …

The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial.

M Zarrabi, MG Akbari, M Amanat, A Majmaa… - BMC …, 2022 - search.ebscohost.com
Abstract < bold> Introduction: </bold> The current multi-center, randomized, double-
blind study was conducted among children with cerebral palsy (CP) to assess the safety and …

The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial

M Zarrabi, MG Akbari, M Amanat, A Majmaa… - 2022 - pubmed.ncbi.nlm.nih.gov
Introduction The current multi-center, randomized, double-blind study was conducted among
children with cerebral palsy (CP) to assess the safety and efficacy of umbilical cord blood …

The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial

M Zarrabi, MG Akbari, M Amanat, A Majmaa… - BMC …, 2022 - search.proquest.com
Methods Males and females aged 4 to 14 years old with spastic CP were included. Eligible
participants were allocated in 4: 1 ratio to be in the experimental or control groups; …

[HTML][HTML] The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled …

M Zarrabi, MG Akbari, M Amanat, A Majmaa… - BMC …, 2022 - ncbi.nlm.nih.gov
Methods Males and females aged 4 to 14 years old with spastic CP were included. Eligible
participants were allocated in 4: 1 ratio to be in the experimental or control groups; …

The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial.

M Zarrabi, MG Akbari, M Amanat, A Majmaa… - BMC …, 2022 - europepmc.org
Methods Males and females aged 4 to 14 years old with spastic CP were included. Eligible
participants were allocated in 4: 1 ratio to be in the experimental or control groups; …